These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Valdecoxib: a review of its use in the management of osteoarthritis, rheumatoid arthritis, dysmenorrhoea and acute pain. Fenton C; Keating GM; Wagstaff AJ Drugs; 2004; 64(11):1231-61. PubMed ID: 15161329 [TBL] [Abstract][Full Text] [Related]
43. Lumiracoxib for acute postoperative dental pain: a systematic review of randomized clinical trials. Silva RC; Riera R; Saconato H Sao Paulo Med J; 2011; 129(5):335-45. PubMed ID: 22069133 [TBL] [Abstract][Full Text] [Related]
44. Long-term efficacy and safety of lumiracoxib 100 mg: an open-label extension of a 13-week randomized controlled trial in patients with primary osteoarthritis of the knee. Sheldon EA; Beaulieu A; Paster Z; Yu S; Rebuli R Clin Exp Rheumatol; 2008; 26(4):611-9. PubMed ID: 18799092 [TBL] [Abstract][Full Text] [Related]
46. Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis. Kivitz AJ; Nayiager S; Schimansky T; Gimona A; Thurston HJ; Hawkey C Aliment Pharmacol Ther; 2004 Jun; 19(11):1189-98. PubMed ID: 15153172 [TBL] [Abstract][Full Text] [Related]
47. Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis. van Walsem A; Pandhi S; Nixon RM; Guyot P; Karabis A; Moore RA Arthritis Res Ther; 2015 Mar; 17(1):66. PubMed ID: 25879879 [TBL] [Abstract][Full Text] [Related]
48. Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo. Sheldon E; Beaulieu A; Paster Z; Dutta D; Yu S; Sloan VS Clin Ther; 2005 Jan; 27(1):64-77. PubMed ID: 15763607 [TBL] [Abstract][Full Text] [Related]
50. How to advise aspirin use in patients who need NSAIDs. Sopena F; Lanas A Curr Pharm Des; 2007; 13(22):2248-60. PubMed ID: 17691998 [TBL] [Abstract][Full Text] [Related]
51. The post-operative analgesic efficacy and tolerability of lumiracoxib compared with placebo and naproxen after total knee or hip arthroplasty. Chan VW; Clark AJ; Davis JC; Wolf RS; Kellstein D; Jayawardene S Acta Anaesthesiol Scand; 2005 Nov; 49(10):1491-500. PubMed ID: 16223396 [TBL] [Abstract][Full Text] [Related]
52. Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain. Clemett D; Goa KL Drugs; 2000 Apr; 59(4):957-80. PubMed ID: 10804043 [TBL] [Abstract][Full Text] [Related]
53. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib. Fleischmann R; Sheldon E; Maldonado-Cocco J; Dutta D; Yu S; Sloan VS Clin Rheumatol; 2006 Feb; 25(1):42-53. PubMed ID: 16132165 [TBL] [Abstract][Full Text] [Related]
54. The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis. Spiegel BM; Targownik L; Dulai GS; Gralnek IM Ann Intern Med; 2003 May; 138(10):795-806. PubMed ID: 12755551 [TBL] [Abstract][Full Text] [Related]
55. Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac - an Indian experience. Pareek A; Chandanwale AS; Oak J; Jain UK; Kapoor S Curr Med Res Opin; 2006 May; 22(5):977-88. PubMed ID: 16709320 [TBL] [Abstract][Full Text] [Related]
56. Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: a phase II, four-week, multicenter, randomized, double-blind, placebo-controlled trial. Schnitzer TJ; Beier J; Geusens P; Hasler P; Patel SK; Senftleber I; Gitton X; Moore A; Sloan VS; Poór G Arthritis Rheum; 2004 Aug; 51(4):549-57. PubMed ID: 15334426 [TBL] [Abstract][Full Text] [Related]
57. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis. Rabeneck L; Goldstein JL; Vu A; Mayne TJ; Rublee DA Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577 [TBL] [Abstract][Full Text] [Related]
58. A validated high-performance liquid chromatographic assay for determination of lumiracoxib in human plasma. Cheremina O; Brune K; Hinz B Biomed Chromatogr; 2006 Oct; 20(10):1033-7. PubMed ID: 16602135 [TBL] [Abstract][Full Text] [Related]
59. COXIBs, CINODs and H₂S-releasing NSAIDs: current perspectives in the development of safer non steroidal anti-inflammatory drugs. Fiorucci S; Distrutti E Curr Med Chem; 2011; 18(23):3494-505. PubMed ID: 21756233 [TBL] [Abstract][Full Text] [Related]